SCHEMBL27238682

SCHEMBL27238682

CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCC(=O)OC(COC(=O)CNC(=O)OC(C)(C)C)COC(=O)CNC(=O)OC(C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
PRKCA P17252 2/20 0.51
PRKCE Q02156 1/20 0.51
PRKCQ Q04759 1/20 0.51
PRKCD Q05655 1/20 0.51
KDM4E B2RXH2 2/20 0.49
SELP P16109 1/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 3/20 0.48
CNR1 P21554 2/20 0.48
MAPT P10636 2/20 0.48
BLM P54132 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
TRPV1 Q8NER1 1/20 0.48
ALOX12 P18054 1/20 0.48
FAAH O00519 1/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27216392 1.00 MEN1 (0.52) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL30902500 0.97 PRKCA (0.54) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL30902507 0.97 PRKCA (0.54) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL30902504 0.93 PRKCA (0.60) PRKCAPRKCEPRKCQPRKCDSELP
SCHEMBL30902499 0.93 PRKCA (0.60) PRKCAPRKCEPRKCQPRKCDSELP
SCHEMBL27216389 0.87 MEN1 (0.55) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL27216390 0.85 MEN1 (0.56) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL27238684 0.83 FAAH (0.61) SELPTRPV1FAAH
SCHEMBL30902505 0.83 PRKCA (0.57) MEN1KMT2APRKCAPRKCEPRKCQ
SCHEMBL7755332 0.82 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240189235-A1 CATIONIC LIPIDS AND USES THEREOF MELLO BIOTECH TAIWAN CO., LTD. (TW) 2024-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240189235-A1 CATIONIC LIPIDS AND USES THEREOF LIPA, APOB, NPC1 MEN1 1260/4885KMT2A 2755/4885PRKCA 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.